Products for Research Use Only
RegisterLogin

Acalabrutinib

CAT: 0013-GTR19171074-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19171074-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Acalabrutinib (ACP-196) is an oral Bruton's tyrosine kinase (BTK) inhibitor used in research for B-cell malignancies. It blocks BCR signaling, inhibiting malignant B-cell proliferation and survival. This small molecule is applied in both in vitro and in vivo studies of diseases like chronic lymphocytic leukemia and mantle cell lymphoma.
CAS Number
1420477-60-6
Product Name Alternative
ACP-196
Field of Research
Immunology & Inflammation
Purity
>98%
Bioactivity
Highly selective BTK inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
CC#CC (=O) N1CCC[C@H]1c1nc (-c2ccc (cc2) C (=O) Nc2ccccn2) c2c (N) nccn12
Molecular Formula
C26H23N7O2
Molecular Weight
465.52
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[8-Amino-3-[ (2S) -1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide

Alternative Products

CatalogName
FA138815-01Acalabrutinib
HY-17600R-01Acalabrutinib (Standard)
AR-A05277-01Acalabrutinib-d4
BUP12133-01Acalabrutinib enantiomer
AR-A08073-01R-Acalabrutinib
HY-W757743Acalabrutinib-d3
JH919586Acalabrutinib Intermediate

Popular Products